2020 Rivaroxaban Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations

2020 Rivaroxaban Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations

  • March 2020 •
  • Report ID: 5796739 •
  • Format: PDF
2020 Rivaroxaban Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations

This new report provides analysis of Calcitonin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.

Geographic Coverage

France, Germany, Italy, Japan, Spain, UK, USA

Market Segmentation
Centralized Testing
- Hospitals
- Commercial/Private Laboratories

POC/Decentralized Testing
- Physician Offices/Group Practices
- Ambulatory Care Centers
- ICUs/CCUs
- Cancer Clinics
- Surgery Center

List of Tables

France: Rivaroxaban Test Volume and Diagnostics Sales Forecasts by Market Segment

Germany: Rivaroxaban Test Volume and Diagnostics Sales Forecasts by Market Segment

Italy: Rivaroxaban Test Volume and Diagnostics Sales Forecasts by Market Segment

Japan: Rivaroxaban Test Volume and Diagnostics Sales Forecasts by Market Segment

Spain: Rivaroxaban Test Volume and Diagnostics Sales Forecasts by Market Segment

UK: Rivaroxaban Test Volume and Diagnostics Sales Forecasts by Market Segment

USA: Rivaroxaban Test Volume and Diagnostics Sales Forecasts by Market Segment